207 related articles for article (PubMed ID: 30713717)
21. Metformin as a Treatment Strategy for Sjögren's Syndrome.
Kim J; Kim YS; Park SH
Int J Mol Sci; 2021 Jul; 22(13):. PubMed ID: 34281285
[TBL] [Abstract][Full Text] [Related]
22. Aberrant expression of BAFF by B lymphocytes infiltrating the salivary glands of patients with primary Sjögren's syndrome.
Daridon C; Devauchelle V; Hutin P; Le Berre R; Martins-Carvalho C; Bendaoud B; Dueymes M; Saraux A; Youinou P; Pers JO
Arthritis Rheum; 2007 Apr; 56(4):1134-44. PubMed ID: 17393395
[TBL] [Abstract][Full Text] [Related]
23. Saliva as an ideal milieu for emerging diagnostic approaches in primary Sjögren's syndrome.
Baldini C; Gallo A; Perez P; Mosca M; Alevizos I; Bombardieri S
Clin Exp Rheumatol; 2012; 30(5):785-90. PubMed ID: 23009763
[TBL] [Abstract][Full Text] [Related]
24. Identification of transitional type II B cells in the salivary glands of patients with Sjögren's syndrome.
Daridon C; Pers JO; Devauchelle V; Martins-Carvalho C; Hutin P; Pennec YL; Saraux A; Youinou P
Arthritis Rheum; 2006 Jul; 54(7):2280-8. PubMed ID: 16802367
[TBL] [Abstract][Full Text] [Related]
25. Co-culture system of human salivary gland epithelial cells and immune cells from primary Sjögren's syndrome patients: an in vitro approach to study the effects of Rituximab on the activation of the Raf-1/ERK1/2 pathway.
Lisi S; Sisto M; D'Amore M; Lofrumento DD
Int Immunol; 2015 Apr; 27(4):183-94. PubMed ID: 25381666
[TBL] [Abstract][Full Text] [Related]
26. T cell subpopulations in the labial minor salivary gland histopathologic lesion of Sjögren's syndrome.
Skopouli FN; Fox PC; Galanopoulou V; Atkinson JC; Jaffe ES; Moutsopoulos HM
J Rheumatol; 1991 Feb; 18(2):210-4. PubMed ID: 1827160
[TBL] [Abstract][Full Text] [Related]
27. Decreased expression of thymic stromal lymphopoietin in salivary glands of patients with primary Sjögren's syndrome is associated with increased disease activity.
Hillen MR; Kruize AA; Bikker A; Wenting-van Wijk M; Radstake TR; Hack CE; Lafeber FP; van Roon JA
Mod Rheumatol; 2016; 26(1):105-9. PubMed ID: 25995032
[TBL] [Abstract][Full Text] [Related]
28. Targeting the Ca(2+) Sensor STIM1 by Exosomal Transfer of Ebv-miR-BART13-3p is Associated with Sjögren's Syndrome.
Gallo A; Jang SI; Ong HL; Perez P; Tandon M; Ambudkar I; Illei G; Alevizos I
EBioMedicine; 2016 Aug; 10():216-26. PubMed ID: 27381477
[TBL] [Abstract][Full Text] [Related]
29. Sjögren's syndrome: from pathogenesis to novel therapeutic targets.
Barone F; Colafrancesco S
Clin Exp Rheumatol; 2016; 34(4 Suppl 98):58-62. PubMed ID: 27586806
[TBL] [Abstract][Full Text] [Related]
30. Alleviating effect of paeoniflorin-6'-O-benzene sulfonate in antigen-induced experimental Sjögren's syndrome by modulating B lymphocyte migration via CXCR5-GRK2-ERK/p38 signaling pathway.
Chen X; Zhang P; Liu Q; Zhang Q; Gu F; Xu S; Körner H; Wu H; Wei W
Int Immunopharmacol; 2020 Mar; 80():106199. PubMed ID: 31955068
[TBL] [Abstract][Full Text] [Related]
31. Immunization with short peptides from the 60-kDa Ro antigen recapitulates the serological and pathological findings as well as the salivary gland dysfunction of Sjogren's syndrome.
Scofield RH; Asfa S; Obeso D; Jonsson R; Kurien BT
J Immunol; 2005 Dec; 175(12):8409-14. PubMed ID: 16339583
[TBL] [Abstract][Full Text] [Related]
32. Inflammation in Sjögren's syndrome: Cause or consequence?
Rodrigues AR; Soares R
Autoimmunity; 2017 May; 50(3):141-150. PubMed ID: 28276715
[TBL] [Abstract][Full Text] [Related]
33. Proteomic diagnosis of Sjögren's syndrome.
Giusti L; Baldini C; Bazzichi L; Bombardieri S; Lucacchini A
Expert Rev Proteomics; 2007 Dec; 4(6):757-67. PubMed ID: 18067414
[TBL] [Abstract][Full Text] [Related]
34. B-lymphocytes govern the pathogenesis of Sjögren's syndrome.
Youinou P; Saraux A; Pers JO
Curr Pharm Biotechnol; 2012 Aug; 13(10):2071-7. PubMed ID: 22208653
[TBL] [Abstract][Full Text] [Related]
35. Invariant NKT cells are expanded in peripheral blood but are undetectable in salivary glands of patients with primary Sjögren's syndrome.
Guggino G; Ciccia F; Raimondo S; Giardina G; Alessandro R; Dieli F; Sireci G; Triolo G
Clin Exp Rheumatol; 2016; 34(1):25-31. PubMed ID: 26633038
[TBL] [Abstract][Full Text] [Related]
36. Phosphatidylinositol 3-kinase delta pathway: a novel therapeutic target for Sjögren's syndrome.
Nayar S; Campos J; Smith CG; Iannizzotto V; Gardner DH; Colafrancesco S; Pipi E; Kollert F; Hunter KJ; Brewer C; Buckley CD; Bowman SJ; Priori R; Valesini G; Juarez M; Fahy WA; Fisher BA; Payne A; Allen RA; Barone F
Ann Rheum Dis; 2019 Feb; 78(2):249-260. PubMed ID: 30472652
[TBL] [Abstract][Full Text] [Related]
37. JAK Inhibitors Suppress Innate Epigenetic Reprogramming: a Promise for Patients with Sjögren's Syndrome.
Charras A; Arvaniti P; Le Dantec C; Arleevskaya MI; Zachou K; Dalekos GN; Bordon A; Renaudineau Y
Clin Rev Allergy Immunol; 2020 Apr; 58(2):182-193. PubMed ID: 31165348
[TBL] [Abstract][Full Text] [Related]
38. TGF-β Pathway in Salivary Gland Fibrosis.
Zhang X; Yun JS; Han D; Yook JI; Kim HS; Cho ES
Int J Mol Sci; 2020 Nov; 21(23):. PubMed ID: 33266300
[TBL] [Abstract][Full Text] [Related]
39. T-cell receptor V-gene usage in Sjögren's syndrome.
Fredriksen C; Johannessen AC; Jonsson R
Adv Exp Med Biol; 1995; 371B():1203-6. PubMed ID: 7502784
[No Abstract] [Full Text] [Related]
40. Dysregulated Marginal Zone B Cell Compartment in a Mouse Model of Sjögren's Syndrome with Ocular Inflammation.
Singh N; Chin I; Gabriel P; Blaum E; Masli S
Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30314337
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
